oxaliplatin medac 150 mg
tzamal bio-pharma ltd - oxaliplatin - powder for solution for infusion - oxaliplatin 150 mg/vial - oxaliplatin - oxaliplatin - oxaliplatin in combination with 5-fluorouracil (5-fu) and folinic acid (fa) is indicated for: • adjuvant treatment of stage iii (duke‘s c) colon cancer after complete resection of primary tumor. • treatment of metastatic colorectal cancer. oxaliplatin in combination with leucovorin, irinotecan and 5-fluorouracil is indicated for the first-line treatment of patients with metastatic pancreatic adenocarcinoma (based on nccn guidelines, version 2.2014).
oxaliplatin medac 100mg powder powder for solution for infusion
medac, germany - oxaliplatin - powder for solution for infusion - 100 mg
oxaliplatin medac 150mg powder powder for solution for infusion
medac, germany - oxaliplatin - powder for solution for infusion - 150 mg
oxaliplatin medac 50mg powder powder for solution for infusion
medac, germany - oxaliplatin - powder for solution for infusion - 50 mg
hydroxyurea medac 500 mg
tzamal bio-pharma ltd - hydroxycarbamide - capsules - hydroxycarbamide 500 mg - hydroxycarbamide - treatment of patient with chronic myeloid leukaemia (cml) in the chronic or accelerated phase of the disease.treatment of patients with essential thrombocytaemia or polycythaemia vera with a high risk for thrmboembolic complications.
dacarbazine medac powder for solution for infusion
medac, germany - dacarbazine - powder for solution for infusion - 100 mg
dacarbazine medac powder for solution for injection/infusion
medac, germany - dacarbazine - powder for solution for injection/infusion - 200 mg
dacarbazine medac powder for solution for injection/infusion
medac, germany - dacarbazine - powder for solution for injection/infusion - 500 mg
solcoseryl jelly 20% 8.3 mg/g
مستودع خوري - khoury drug store - protein-free haemodialysate of calves' blood 8.3 mg/g - 8.3 mg/g
disflatyl drops 40 mg/ml
مستودع خوري - khoury drug store - simethicone 40 mg/ml - 40 mg/ml